SLIDE 01 • THE PROBLEMUse Arrow Keys ← → to navigate
The Crisis of Reactive Medicine
Healthcare spends $4T+ treating broken parts instead of upstream root causes
Modern healthcare is designed around acute failure: waiting for an organ to break, assigning an ICD-10 code, and prescribing lifelong medications to manage symptoms.
The Downstream Trap
By the time a patient is diagnosed with Type-2 Diabetes or Atherosclerosis, subclinical metabolic drift and vascular wear have been silently occurring for 7 to 10 years.
The Biopharma Bottleneck
Global clinical trials lack diverse longitudinal RWE, costing biopharma billions in synthetic control arms and failed patient recruitments.